Call to Action: Finding Solutions for the Drug Shortage Crisis in the United States

In their article in this issue of CPT, Woodcock and Wosinska are the first to clearly outline the quality and manufacturing problems causing drug shortages of generic injectables. These authors have focused on the main issue, namely, that manufacturing problems and the lack of incentives for quality products are the primary reasons for most recent shortages of generic injectable drugs. Clinical Pharmacology & Therapeutics (2013); 93 2, 145–147. doi:10.1038/clpt.2012.225